Dexcom Finds New Partner in Oura Smart

The San Diego, CA-based company is also investing $75 million in Oura’s Series D financing.

Omar Ford

November 20, 2024

1 Min Read
Alena Butusava via iStock / Getty Images

Dexcom has experienced some intense highs and lows this year. The highs were the release of the Stelo, an over-the-counter glucose monitor with the lows being a troubling 2nd quarter that caused shares to drop by 45%.

The San Diego, CA-based company experienced another high this week when it announced it was working with Oura, the developer of smart ring.

The deal calls for the integration of the Dexcom glucose data with vital signs, sleep, stress, heart health, and activity data from Oura Ring.  Dexcom is also making a $75 million strategic investment in the Ōura Series D funding, with Ōura now valued at more than $5 billion.

Dexcom and Ōura will launch integrations enabling data to flow between Dexcom and Ōura products, including Dexcom glucose biosensors, Dexcom apps, Oura Ring, and the Oura App, so shared users can track their glucose levels and understand the impact of behaviors and biology on their metabolic health. The companies will also co-market and cross-sell each other’s products. The first app integration resulting from the partnership is expected to launch in the first half of 2025.

“Ninety-seven percent of Oura Members have expressed interest in understanding how the food they eat impacts their health,” said Tom Hale, Ōura CEO. “This partnership with Dexcom will enable us to empower our members to make informed decisions and adjust behaviors to positively impact their biometrics and long-term health. Working together, Ōura and Dexcom will help members decide what and when to eat by surfacing correlations between activities like sleep and exercise and members’ glucose levels. And because we know that people are affected differently by the same foods and activities, guidance and insights will be personalized.”

Related:Glucotrack Begins Enrollment for Long-term Implantable CGM Study

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like